Intelligent Bio Solutions
INBS
8 hedge funds and large institutions have $868K invested in Intelligent Bio Solutions in 2021 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 5 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
0% less ownership
Funds ownership: 0% → 0% (-0%)
20% less funds holding
Funds holding: 10 → 8 (-2)
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
74% less capital invested
Capital invested by funds: $3.36M → $868K (-$2.49M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$307K |
| 2 |
Bank of New York Mellon
New York
|
+$99.7K |
| 3 |
BlackRock
New York
|
+$69K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$23K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$15.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$2.25M |
| 2 |
VF
Virtu Financial
New York
|
-$98K |
| 3 |
Goldman Sachs
New York
|
-$77K |
| 4 |
Jane Street
New York
|
-$75K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$68K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Geode Capital Management
Boston,
Massachusetts
| $273K | +$307K | +40 | +800% |
|
|
BCM
2
Bridgeway Capital Management
Houston,
Texas
| $252K | -$53.7K | -7 | -14% |
|
|
WP
3
WealthShield Partners
Cary,
North Carolina
| $124K | – | – | – |
|
|
4
Bank of New York Mellon
New York
| $78K | +$99.7K | +13 | New |
|
|
5
Vanguard Group
Malvern,
Pennsylvania
| $61K | +$15.3K | +2 | +25% |
|
|
6
BlackRock
New York
| $55K | +$69K | +9 | New |
|
|
7
UBS Group
Zurich,
Switzerland
| $16K | +$23K | +3 | New |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| $8K | – | – | – |
|
9
Morgan Stanley
New York
| $1K | – | – | – |
|
|
AFM
10
Anson Funds Management
Dallas,
Texas
| – | -$2.25M | -238 | Closed |
|
|
VF
11
Virtu Financial
New York
| – | -$98K | -10 | Closed |
|
|
12
Goldman Sachs
New York
| – | -$77K | -8 | Closed |
|
|
13
Jane Street
New York
| – | -$75K | -8 | Closed |
|
|
14
Citadel Advisors
Miami,
Florida
| – | -$68K | -7 | Closed |
|
INBS Hedge Fund Activity: Q3 2021 in Review
8 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Intelligent Bio Solutions (INBS) for Q3 2021, worth a combined $868K — down 74% from $3.36M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of INBS and 3 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 2 added.
The largest buyer was Geode Capital Management, adding an estimated $307K. The largest seller was Anson Funds Management, exiting entirely with an estimated $2.25M sold.
- 8 institutional investors held Intelligent Bio Solutions (INBS) as of Q3 2021, down from 10 in Q2 2021.
- Funds reported $868K of Intelligent Bio Solutions stock for Q3 2021, down 74% quarter-over-quarter.
- 3 funds opened new Intelligent Bio Solutions positions in Q3 2021 and 5 closed out, a net change of -2 holders.
- The largest Intelligent Bio Solutions buyer in Q3 2021 was Geode Capital Management, an estimated $307K added.
- The largest Intelligent Bio Solutions seller in Q3 2021 was Anson Funds Management, an estimated $2.25M sold.
Based on aggregated 13F filings for Q3 2021.